Mihaela Skobe, PhD
Principal Investigator
Dr. Skobe obtained her bachelor’s degree in Molecular Biology at the University of Zagreb (Croatia) and completed her PhD in Cell Biology at the German Cancer Research Center in Heidelberg and at the University of Darmstadt (Germany). She performed her postdoctoral work at the Massachusetts General Hospital/Harvard Medical School, where she pioneered the studies of tumor lymphangiogenesis. She is an Associate Professor in the Department of Oncological Sciences at the Icahn School of Medicine at Mount Sinai and the Tisch Cancer Center. Dr. Skobe serves on many advisory committees and review boards nationally and internationally. She is the recipient of several prestigious awards and she was honored by the Lymphatic Research Foundation for her seminal contributions to the field.
Ruben Fernandez-Rodriguez, PhD
Postdoctoral Fellow
Dr. Fernandez-Rodriguez obtained his BSc in Biotechnology from the Francisco de Vitoria University (Madrid, Spain) and his PhD in Biomedicine from the University of Granada (Spain). In his previous postdoctoral research at the National University of Singapore (Singapore), he studied the role of ADAMTSs proteases in tumor angiogenesis and how they influence tumor growth and metastasis in different mouse models of cancer. Dr. Fernandez-Rodriguez joined Dr. Skobe’s lab in 2017 and is investigating lymphatic metastases at single-cell resolution using intravital multiphoton microscopy.
Andrew Edwards, PhD
Postdoctoral Fellow
Dr. Edwards earned his BSc and MS degrees in Biomedical and Molecular Sciences from the University of Guelph (Canada) and obtained a PhD in Anatomy and Cell Biology from Queen’s University (Canada). His graduate research focused on angiogenesis in the female reproductive system and on identifying novel anti-angiogenic peptides for endometriosis. He previously worked as a Postdoctoral Scientist at the Columbia University Medical Center studying Notch signaling in infantile hemangioma. He joined Dr. Skobe’s lab in 2017, and his current research investigates the role of chemokines in melanoma metastasis.
